]>
IRCT20220815055703N1 IRCT 2022-11-15 Ahvaz University of Medical Sciences Investigating the effect of chest physiotherapy in the treatment of covid-19 The effect of chest physiotherapy on the clinical outcomes of patients with COVID 19 2022-10-07 anticipated 52 Complete https://irct.ir/trial/65321 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: For randomization, we use the method of block randomization with blocks with size of 4 and for this purpose, we prepare four sheets of paper. On the two sheets we write the letter I meaning "Intervention" and on the other two sheets we write the letter C meaning "Control". Mix the sheets together and place them in the desk drawer. Upon referral to any of the eligible patients, one of the sheets will be randomly pulled out and based on this sheet being drawn I or C will be assigned to one of the two intervention or comparison groups. N/A Investigating the effect of chest physiotherapy on the recovery of patients with covid-19. Intervention 1: Intervention group: Patients in the intervention group will undergo chest physiotherapy in addition to routine care related to the care of patients with covid-19. Chest physiotherapy intervention will be done for six days and every morning and evening for 20 minutes. Physiotherapy of the chest will also be performed by the physiotherapist of the centers every morning and evening. At the end of the third and sixth days, the patients of both groups will be evaluated in terms of FEV1/FVC, FEV1, and FVC parameters using the clinical status survey form. Intervention 2: Control group: patients in the control group only receive routine care (depending on the severity of the disease and the underlying diseases of the patient, including oxygen therapy, required supportive treatments, preventive anticoagulation treatment, diagnostic tests, imaging procedures, emphasis on healthy eating and rest sufficient) related to the care of patients with covid-19 will receive. At the end of the third and sixth days, the patients of both groups will be evaluated in terms of FEV1/FVC, FEV1, and FVC parameters using the clinical status survey form. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no further information
public Reza Moradi Azgil
No. 17 Amar St
Iezh Iran (Islamic Republic of) 15794 - 61357 +98 61 4363 1059 rezanurs73@gmail.com Ahvaz University of Medical Sciences scientific Reza Moradi Azgil
No. 17 Amar St
Iezh Iran (Islamic Republic of) 15794 - 61357 +98 61 4363 1059 rezanurs73@gmail.com Ahvaz University of Medical Sciences Iran (Islamic Republic of) Desire to participate in the study The average severity of the disease based on the diagnosis of a doctor specializing in respiratory diseases Hospitalization at the time of diagnosis Not using other chest physiotherapy programs at the same time Absence of underlying diseases such as cancer, cardiovascular diseases and diabetes Patient alertness Able to perform chest physiotherapy activities no limit no limit Both Reluctance or refusal to participate in the study Changing the level of severity of the disease from moderate to severe level of the disease Having respiratory failure U07.1 COVID-19, virus identified Treatment - Devices Treatment - Drugs Intervention group: Patients in the intervention group will undergo chest physiotherapy in addition to routine care related to the care of patients with covid-19. Chest physiotherapy intervention will be done for six days and every morning and evening for 20 minutes. Physiotherapy of the chest will also be performed by the physiotherapist of the centers every morning and evening. At the end of the third and sixth days, the patients of both groups will be evaluated in terms of FEV1/FVC, FEV1, and FVC parameters using the clinical status survey form. Control group: patients in the control group only receive routine care (depending on the severity of the disease and the underlying diseases of the patient, including oxygen therapy, required supportive treatments, preventive anticoagulation treatment, diagnostic tests, imaging procedures, emphasis on healthy eating and rest sufficient) related to the care of patients with covid-19 will receive. At the end of the third and sixth days, the patients of both groups will be evaluated in terms of FEV1/FVC, FEV1, and FVC parameters using the clinical status survey form. Vital capacity (FEV2/FVC ratio). Timepoint: Before starting the intervention and at the end of the sixth day after the start of the intervention (physiotherapy). Method of measurement: Spirometry device. Arterial blood gases include: (PaO2), (PaCO2), (SaO2), (PaO2/FiO2). Timepoint: Before starting the intervention and at the end of the sixth day after the start of the intervention (physiotherapy). Method of measurement: Arterial blood test. Vital capacity Vital capacity (FEV2/FVC ratio). Timepoint: At the end of the third and sixth days after the intervention (physiotherapy). Method of measurement: Spirometry device. Arterial blood gases include: (PaO2), (PaCO2), (SaO2), (PaO2/FiO2). Timepoint: At the end of the sixth day after the start of the intervention (physiotherapy). Method of measurement: Arterial blood test. Ahvaz University of Medical Sciences Approved 2022-07-30 Ethics Committee of Jundi Shapur Ahvaz University of Medical Sciences Boulevard of Medical Sciences, Ahvaz, Khuzestan Province Ahvaz Khouzestan Iran (Islamic Republic of)